Medicine and Dentistry
Melanoma
100%
Neoplasm
82%
Diseases
42%
Malignant Neoplasm
38%
Metastatic Carcinoma
33%
Metastatic Melanoma
28%
Overall Survival
27%
Breast Cancer
26%
Sentinel Node
22%
Retroperitoneal Lymph Node Dissection
21%
Sentinel Lymph Node
21%
Lymph Node
21%
Lymph Duct
18%
Melanoma Skin Cancer
17%
Colorectal Carcinoma
17%
Recurrent Disease
17%
Brain Metastasis
17%
Immunotherapy
16%
Cancer
16%
Melanoma Cell
13%
Colon Carcinoma
12%
Primary Tumor
10%
Radiation Therapy
10%
Clinical Trial
10%
Biological Marker
9%
Biopsy Technique
9%
Surgeon
9%
Drug Megadose
9%
Skull Base
9%
Transsphenoidal Surgery
8%
Progression Free Survival
8%
Interleukin 2
8%
Phase II Trials
8%
Prostate Cancer
7%
Messenger RNA
7%
Tumor Cell
7%
Micrometastasis
7%
Circulating Tumor Cell
7%
Adjuvant Therapy
6%
Survival Rate
6%
Disease Free Survival
6%
High Dose Chemotherapy
6%
Positron Emission Tomography
6%
Clear Cell Renal Cell Carcinoma
6%
T Cell
6%
Prognostic Factor
6%
Oncology
6%
Glioblastoma
6%
Multivariate Analysis
6%
Magnetic Resonance Imaging
6%
Quality of Life
5%
Arm
5%
Systemic Therapy
5%
Tumor Progression
5%
Lymphocyte
5%
Immunohistochemistry
5%
Hazard Ratio
5%
Pediatrics
5%
Traumatic Brain Injury
5%
Reverse Transcription Polymerase Chain Reaction
5%
Adverse Event
5%
Cell Line
5%
Intracranial Tumor
5%
Methylation
5%
Ipilimumab
5%
Endoscope
5%
Sentinel Lymph Node Biopsy
5%
Breast Carcinoma
5%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
41%
Neoplasm
38%
Diseases
29%
Malignant Neoplasm
27%
Overall Survival
19%
Chemotherapy
17%
Interleukin 2
16%
Breast Cancer
16%
Metastatic Melanoma
15%
Phase II Trials
14%
Progression Free Survival
11%
Prostate Cancer
10%
Colorectal Carcinoma
10%
Recurrent Disease
10%
Solid Malignant Neoplasm
9%
Clinical Trial
9%
Renal Cell Carcinoma
8%
Brain Metastasis
8%
Cisplatin
8%
Immunotherapy
7%
Castration Resistant Prostate Cancer
7%
Biological Marker
7%
Remission
7%
High Dose Chemotherapy
7%
Cytokine
7%
Phase I Trials
6%
Fluorouracil
6%
Adverse Event
6%
Etoposide
6%
Cyclophosphamide
6%
Colon Carcinoma
5%
Pharmacokinetics
5%
Ipilimumab
5%
Lymphokine
5%
Kidney Cancer
5%
Immunology and Microbiology
Immunotherapy
15%
Overall Survival
12%
Melanoma Cell
12%
Drug Megadose
11%
Interleukin 2
11%
Lymph Node
9%
T Cell
8%
Cytokine
8%
Colon
7%
Blood Plasma
6%
Immune Response
6%
Cell Line
6%
Cancer Cell
5%
Peptides
5%
Sentinel Lymph Node
5%
Cytotoxic T Cell
5%
Natural Killer Cell
5%